Sign Up to like & get
recommendations!
1
Published in 2022 at "ChemMedChem"
DOI: 10.1002/cmdc.202200058
Abstract: The design, synthesis, X-ray structural, and biological evaluation of a series of highly potent HIV-1 protease inhibitors are reported herein. These inhibitors incorporated novel cyclohexane-fused tricyclic bis -tetrahydrofuran as P2 ligands in combination with a…
read more here.
Keywords:
synthesis ray;
protease;
potent hiv;
hiv protease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2016.10.009
Abstract: To further explore the chemical space around the entrance channel of HIV-1 reverse transcriptase (RT), a series of novel indolylarylsulfones (IASs) bearing N-substituted piperidine at indole-2-carboxamide were identified as potent HIV NNRTIs by structure-guided scaffold…
read more here.
Keywords:
scaffold morphing;
structure guided;
guided scaffold;
hiv nnrtis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.8b01227
Abstract: We have designed, synthesized, and evaluated a new class of potent HIV-1 protease inhibitors with novel bicyclic oxazolidinone derivatives as the P2 ligand. We have developed an enantioselective synthesis of these bicyclic oxazolidinones utilizing a…
read more here.
Keywords:
potent hiv;
protease;
bicyclic oxazolidinone;
protease inhibitors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2017.1262349
Abstract: ABSTRACT Diaryltriazine derivatives, which are structurally related to diarylpyrimidines, are a representative class of HIV-1 reverse transcriptase inhibitors with remarkable antiviral activities against wild-type and several mutant strains of HIV-1. A series of novel diaryltriazines…
read more here.
Keywords:
potent hiv;
novel diaryltriazines;
hiv;
hiv inhibitors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecules"
DOI: 10.3390/molecules27020461
Abstract: New target molecules, namely, 2-phenylamino-4-phenoxyquinoline derivatives, were designed using a molecular hybridization approach, which was accomplished by fusing the pharmacophore structures of three currently available drugs: nevirapine, efavirenz, and rilpivirine. The discovery of disubstituted quinoline…
read more here.
Keywords:
phenoxyquinoline derivatives;
potent hiv;
phenylamino phenoxyquinoline;
quinoline ... See more keywords